HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial Observational and laboratory studies suggest that some hormonal...
WHO Statement on the Release of ECHO Trial Results Results from the ECHO study, which compared the relative rates of HIV acquisition among women using three contraceptive methods, were inadvertently and temporarily released by a scientific journal on Monday 20 May....
A Roadmap for Results: Supporting Countries to Plan for the ECHO Trial Results This webinar was hosted by AVAC, Breakthrough ACTION, and FP2020 to discuss a new Country Roadmap that provides templates that countries can use before, during, and after the release of...
ECHO Consortium: Resources A collection of WHO guidance, publications, links, and other materials on hormonal contraception and HIV. Published: 2019 Source: ECHO Back to...
Putting Women at the Center: Informed choice in 2018 and beyond We need to give women the choice to use DTG or not and to use contraception if indicated and desired. We need to support choices across options, with risk reduction—not use of a specific product—as the...
Recent Comments